CellMark Medical is pleased to announce a new partnership with Richard Wolf GmbH. With effective from 1 September 2017, CellMark Medical will be the authorized distributor for Richard Wolf in the territory of Hong Kong and Macau.
Richard Wolf is an internationally renowned manufacturer that offers a wide range of products and systems for endoscopy and extracorporeal shock wave treatment. These instruments are supplied to virtually all specialist disciplines in human medicine.
CellMark’s global resource network and trading platform provide a unique hub for advanced medical technology, with offices in 30 countries where Hong Kong is the CellMark Medial Headquarters in the APAC region.
The new partnership is surely an important step for CellMark and our ultimate goal is to fulfill customers’ clinical needs by bringing the latest endoscopy products to every specialty.
For any inquiries, please do not hesitate to call CellMark Medical hotline +852 28821208.
Today we accounce that CellMark partners with Health Invest Finland, a Finnish startup company focusing on smart device technology to improve health care. CellMark’s expertise in medical device distribution, logistics and sales support will enable My+Care™ to gain traction with healthcare facilities around the world. The partnership will cover Asia, Europe, Africa, N America, S America and the Middle East.
Health Invest has developed an innovative health 24/7 service solution in the form of a wristband, My+Care™. The band makes health care mobile and makes it easier to predict and anticipate patients’ needs. It registers a condition or behavior instantly. For instance, if we move or fall the data is analyzed in an app in real time, and help can be sent instantaneously.
We are heading in a direction where there are more people in need of care than there are resources. The My+Care™ technology is developed to be used in the health care sector, for public as well as private establishments. Both patients and providers benefit from this new cloud-based technology which will make health care happen promptly and secure personalized care. Consequently it may save or even extend human lives. With this kind of cloud based technology solutions, we can envision a future of health care that provides us with dignity, security and a valuable way of life while keeping the sense of independency and privacy.
There’s also potential for use of this technology in other areas beyond the health sector which makes it even more interesting.
“I’m very excited to see how our extensive partnership with Health Invest Finland is evolving. Based on mutual trust and transparency, Health Invest Finland and CellMark have created a business concept to secure supply of the My+Care™ hardware and a structure to provide service for customers worldwide. We believe that this agreement and future collaboration between our two companies is the way forward that will lead to sustainable business growth and improved patient outcomes in a world that is ageing fast ”, commented Niclas Möttus Olsson, President CellMark Medical.
CellMark sponsored and participated in the Swedish-American Chamber of Commerce’s workshop on innovation that took place at the House of Sweden, Washington DC earlier this year. We did this as we have high aspirations for the company and want to improve on our ability to innovate and generate the ideas that will make us stronger improving our business offerings going forward.
Now, why does a medical device manufacturer participate in a workshop about innovation together with CellMark?
Follow the interesting video discussion between our medical team and their partner Bioderm. Learn how Bioderm drive innovation and how future collaboration can change the cost for care.
CellMark is please to announce our partnership with AVACEN for the international sale and marketing of the AVACEN-100, Class-II Medical Device globally. Our Medical Division’s sales team is very enthusiastic about the latest addition and see how well this non-drug treament fits into their marketing portfolio. Please refer to AVACEN’s news release for additional information.
CellMark Medical is attending the 77th China International Medical Equipment Fair, the largest medical show in China which will be held on 15-18 May at Shanghai National Exhibition & Convention Centre.
We are proud to participate with Sinopharm at Hall 1, booth 1F-05.
For individual appointment, please contact Mr. Alex Wong at +852 90280246.
Look forward to see you there!
CMEF at a Glance
China International Medicinal Equipment Fair (CMEF) is today the largest fair of medical equipment, related products and services in the Asia-Pacific region. The fair widely covers 15,000 products and it serves the entire value chain of medical devices from the source to the end. At each fair, almost 4,000 medical device manufacturers from over 24 countries, and about 120,000 people who are government procurement agencies, hospital buyers and dealers from over 100 countries and regions gather for trading and exchanges.
On Sept 21, South Korean biotech company ATGen signed a Letter of Intent for strategic alliances with CellMark to expand in the European market with the sale and marketing of ATgen’s product NK Vue Kit. Through CellMark’s global marketing network, ATGen will roll out its NK Vue Kit, which helps to set early diagnosis of Cancer. Under this LOI agreement, ATGen can expect to accelerate overseas expansion and access local market research worldwide. CellMark recently expanded its business to include also Med Tech products and services. CellMark Medical ATGen Co. Ltd. is a biotech company that manufactures and supplies proteins and antibodies worldwide.
NK Vue Kit
In the average human body, there are more than 5,000 abnormal cells such as cancer cells, growing and dying every day. The Natural Killer cell is the only cell that recognizes and attacks cancer cells, which can inhibit from the proliferation of cancer cells and prevent from recurrence. NK Vue is an analysis kit to check activity of Natural Killer cell which can be regarded as an anti-tumor immunity cell. The test can help assess your immune system’s ability to fight disease, providing an early warning signal to trigger additional testing or lifestyle changes.
ATGen Co Ltd’s full press release:
“ATgen announced that ATgen signed a LOI for strategic alliances with CellMark for the sale and marketing of NK Vue Kit on 21st Sep 2016. Both agreed to co-develop a global market expansion and increase sales through CellMark global marketing network. NK Vue is a analysis kit to check activity of Natural Killer cell which can be regarded as an antitumor immunity cell. CellMark, which was founded in Sweden in 1984, is a distributer of raw materials and supply-chain service provider. The annual trade volume reaches 6 million tons, and the Group sales is about 3 billion US dollars. CellMark is a truly global company with a network of 70 offices in 30 countries. Recently, the company leveraged it’s strong marketing and distribute platform expanding present business of Paper, Pulp, Packaging, Recycling, Chemicals, Metals and Energy to also include Bio Heath care and Med Tech. Under this LOI agreement with CellMark, ATgent can expect to accelerate overseas expansion by upgrading global marketing capacity. Local market research can be supported by using CellMark global network, which can also enable to sell NK Vue kit without any direct distributor management. CellMark platform also includes screening services to qualify local distributor and recruit a local employee and also can bring a great momentum to enter new market. CEO of ATgen Mr. Park said, “We could establish a bridgehead to secure an advance foundation for expansion toward unexplored field of Europe and South America. We will pioneer new market together with CellMark.”
CellMark enter into new business area and will together with healthcare entrepreneurs offer products, services and solutions that will improve health and wellbeing globally. CellMark Medical, will enable innovative, small- and mid-sized, medical technology companies to accelerate their growth in emerging markets, predominantly in the Asia Pacific region, and offer an innovative and cost-effective IT platform to our MedTech partners and hospitals for them to do business on.
CellMark’s global presence in combination with the IT system provide a unique opportunity to add value to the global healthcare market in terms of open up new markets, offer distribution of products, consumables, chemicals and in the future drugs at significant lower costs than offered today and with better transparency between the product owners and the end users. The significantly improved transparency offers the product owners unprecedented insights into market needs for their product development.
CellMark Medical provide a global approach to its partners when it comes to product licenses and by that offer a new approach to a global issue in regards to product control. Our partners will have full control of their products on all markets over their life time. The opportunity for the product owners to protect their intellectual property, manage transactions in their home markets, improve data for their product development and at the same time drive growth globally is very attractive. On the receiving end, in emerging markets, local distributers and users will have access to products they need but historically not have had access to. The cost efficient distribution model will ensure that products can be sold at an acceptable price level.
CellMark Medical, will be a solid meeting place for global entrepreneurs. Please do contact any of the team to discuss business opportunities!